Cite
MLA Citation
W.‐L. Chuang et al.. “Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients.” Alimentary pharmacology & therapeutics, vol. 47, no. 9, 2018, pp. 1306–1316. http://access.bl.uk/ark:/81055/vdc_100060625834.0x00004a